This inventor holds 1 USPTO granted patent. Top assignee: Korpharm Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Gil Hong Park: Innovator in Neuroprotective Compositions
Introduction
Gil Hong Park is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of neuroprotection through his innovative research and patent developments. His work focuses on the prevention and treatment of degenerative brain diseases, showcasing his commitment to advancing medical science.
Latest Patents
Gil Hong Park holds a patent for "Compositions containing pterosin compound and derivatives thereof active ingredients for prevention or treatment of degenerative brain diseases." This invention relates to pharmaceutical and food compositions that utilize pterosin compounds as active ingredients. These compositions aim to prevent or alleviate degenerative brain diseases and promote cognitive functions. The patent highlights the potential therapeutic applications of pterosin compounds, which are extracted and utilized for their beneficial properties.
Career Highlights
Throughout his career, Gil Hong Park has demonstrated a strong dedication to research and innovation. His work at Korpharm Co., Ltd. has positioned him as a key player in the development of neuroprotective therapies. His focus on pterosin compounds reflects his commitment to addressing critical health challenges associated with brain degeneration.
Collaborations
Gil Hong Park has collaborated with talented individuals such as Ali Md Yousof and Susoma Jannat. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
In summary, Gil Hong Park is an influential inventor whose work in neuroprotective compositions has the potential to significantly impact the treatment of degenerative brain diseases. His innovative approach and dedication to research continue to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile